Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients

Postpartum Anemia Clinical Trial

Official title:
Safety and Efficacy of a Hematinic Agent in the Treatment of Postpartum Patients

Status Completed

Clinical Trial Summary

The purpose of this study is to evaluate the efficacy, safety, and tolerability of VIT45 compared to the current standard of care in postpartum patients.

Clinical Trial Description

This is an open label Phase III randomized active control study of postpartum patients with anemia. Patients will be randomized to either active control or the investigational agent and followed for up to 6 weeks. ;

Study Design

Related Conditions & MeSH terms

Postpartum Anemia

Clinical Trial Details

NCT number	NCT00354484
Study type	Interventional
Source	Luitpold Pharmaceuticals
Contact
Status	Completed
Phase	Phase 3
Start date	May 2006
Completion date	January 2007

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05590260` - Prevention of Iron Deficiency Anemia Post-delivery	Phase 3
Completed	`NCT01628770` - Use of Iron Isomaltoside 1000 (Monofer) in Postpartum Anemia	N/A
Recruiting	`NCT02656225` - Effect of Ejiao Compound in the Treatment of Postpartum Anemia of Qi-blood Deficiency Syndrome	Phase 1/Phase 2
Completed	`NCT02434653` - A Comparison Between Two Strategies for Postpartum Anemia Diagnosis and Follow up After Vaginal Deliveries	N/A
Not yet recruiting	`NCT06175117` - Clinical Study on the Treatment of Postpartum Anemia With Compound E Jiao Jiang(cEJJ）	Phase 4
Completed	`NCT02458625` - A Comparison Between Intravenous Iron Sucrose to Its Combination With Oral Iron Supplements for the Treatment of Postpartum Anemia	N/A